Pharmaceutical

Eli Lilly wins FDA approval for weight loss pill, boosts rival Novo – Pharmaceutical Technology

by
Eli Lilly wins FDA approval for weight loss pill, boosts rival Novo - Pharmaceutical Technology

Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more

Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in weight loss and beyond

by
Biocytogen and Sihuan Pharmaceutical Announce Strategic Partnership in weight loss and beyond

BEIJING, April 01, 2026–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Pharmacy; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies in multiple disease areas, including weight loss, leveraging complementary strengths to … Read more